Keywords: genentech, boosted, asthma, data, bla, shares, rose
Genentech boosted on asthma data, BLA 2000
Article | 21 December 1999
Shares in Genentech rose 10% on December 17 after the firm reportedpositive preliminary data from pivotal trials of its anti-IgE (rhuMAb-E25) antiasthma ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
